Filling the need for trusted information on national health issues…

Private Sector Involvement

  • Your Selections:

Refine Results

date

Tags

Gilead To License HCV Drug In Bid To Improve Access In Lower-Income Countries

News outlets report on Gilead’s agreement with Indian generic drugmakers to allow production of its hepatitis C medication. Financial Times: Gilead in deal with India labs to produce Sovaldi “Gilead Sciences will allow seven large Indian generic drug producers to make and sell its blockbuster hepatitis C drug Sovaldi in…

Ebola Outbreak Spurs Rise In Search For Treatment, Vaccine, Other Tropical Disease R&D

News outlets report on the search for an effective Ebola treatment. The Economist: Fast-tracking treatments “…The scale of the present [Ebola] outbreak, together with the fear and suffering it is causing, has resulted in a burst of scientific activity to find new treatments and vaccines. Some of these medicines look…

Sanofi Pasteur Works To End Polio By 2018

SciDev.Net: Is the world on track for polio eradication by 2018? “Polio is a viral disease that, until the 1980s, crippled an estimated 350,000 children every year. … SciDev.Net visited the Mérieux campus in Lyon, France, where the pharmaceutical company Sanofi Pasteur works with the Global Polio Eradication Initiative to…

USAID To Invest $6.3M In Public-Private Partnerships To Boost Impact Investing

Thomson Reuters Foundation: U.S. boosts public-private partnerships to grow impact investing “The United States on Thursday announced three public-private partnerships to boost private investment in early-stage enterprises in developing countries as part of its strategy to make impact investing and private sector partnerships a backbone of its development policy. The…

NIH Experimental Ebola Vaccine Trial Begins; Other Vaccines, Treatments Under Development

News outlets report on various aspects of Ebola vaccine and treatment development and delivery. ABC News: Two Women Receive Experimental Ebola Vaccine in Fast-Tracked Trial “The first two doses of an experimental Ebola vaccine have been injected into human subjects in the National Institutes of Health’s fast-tracked clinical trial…” (Lupkin,…

Large Clinical Trial Confirms Efficacy Of Sanofi’s Dengue Vaccine

News outlets report on French drugmaker Sanofi’s announcement that its experimental dengue vaccine has reduced disease cases in a large clinical trial. Bloomberg News: Sanofi Dengue Vaccine Works on All Four Types in Study “Sanofi’s experimental vaccine against dengue protected children with all four types of the mosquito-borne illness in…

NIH To Begin Ebola Vaccine Safety Clinical Trial In Humans

News outlets report on an Ebola vaccine human clinical trial scheduled to begin next week. ABC News: U.S. to Test Ebola Vaccine in Humans Amid Growing Outbreak in West Africa “U.S. scientists will begin testing an Ebola vaccine in humans next week, health officials announced [Thursday]. But it could take…

GSK Experimental Ebola Vaccine Soon To Be Tested In Humans

News outlets report on GlaxoSmithKline’s (GSK) plans to test its experimental Ebola vaccine in humans. Bloomberg News: Glaxo’s Ebola Vaccine to Be Tested for Safety in Humans “U.S. scientists will begin enrolling patients as soon as next week in clinical safety trials of GlaxoSmithKline Plc (GSK)’s experimental Ebola vaccine as…

The Henry J. Kaiser Family Foundation Headquarters: 2400 Sand Hill Road, Menlo Park, CA 94025 | Phone 650-854-9400
Washington Offices and Barbara Jordan Conference Center: 1330 G Street, NW, Washington, DC 20005 | Phone 202-347-5270

www.kff.org | Email Alerts: kff.org/email | facebook.com/KaiserFamilyFoundation | twitter.com/KaiserFamFound

Filling the need for trusted information on national health issues, the Kaiser Family Foundation is a nonprofit organization based in Menlo Park, California.